Results 301 to 310 of about 269,013 (347)
Some of the next articles are maybe not open access.
Treatment of bipolar depression
Psychiatric Services, 1995(MAOIs) may be especially effective in the treatment of bipolar depression that is refractory to tricyclic antidepressants, especially depression with anergic features (7). There are no studies comparing the efficacy of MAOIs and selective serotonin reuptake inhibitors (SSRIs) in the treatment ofbipolar depression.
A, Dantzler, C, Salzman
openaire +2 more sources
Zonisamide for bipolar depression
Expert Opinion on Pharmacotherapy, 2006In recent years, research into bipolar depression has increased. Each year, more studies are published using different agents to treat this condition. In addition to effectiveness and tolerability, bipolar depression research has sought agents that do not induce cycling or mania.
Michael S, Wilson, Robert L, Findling
openaire +2 more sources
Treatment of bipolar depression
Medical Journal of Australia, 2012Depression is usually the predominant phase in bipolar disorder, causes the most psychosocial disability, and carries significant risk of suicide. The management of bipolar depression is relatively under-studied and poses significant challenges for clinicians.
Michael, Berk +8 more
openaire +2 more sources
Nutrition and Bipolar Depression
Psychiatric Clinics of North America, 2016As with physical conditions, bipolar disorder is likely to be impacted by diet and nutrition. Patients with bipolar disorder have been noted to have relatively unhealthy diets, which may in part be the reason they also have an elevated risk of metabolic syndrome and obesity.
John L, Beyer, Martha E, Payne
openaire +2 more sources
TREATMENT-RESISTANT BIPOLAR DEPRESSION
Psychiatric Clinics of North America, 1996Patients with treatment-resistant bipolar depression require careful management, which takes into account the life-threatening potential of their depression and the risk of iatrogenic mania. Because there are few data specific to treatment of bipolar depression, much of the approach to bipolar depression is derived from experience with unipolar ...
openaire +2 more sources
Quetiapine monotherapy for bipolar depression
Expert Opinion on Pharmacotherapy, 2011Depression, in the context of bipolar disorder, is more prevalent than hypomania or mania and accounts for most of the disability. Furthermore, the treatment of bipolar depression is more complicated than the treatment of unipolar major depression. Finally, the evidence base for pharmacotherapy of bipolar depression is much smaller than for unipolar ...
Philip G, Janicak, Jeffrey T, Rado
openaire +2 more sources
Alprazolam in Bipolar‐I Depressions
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1984In an open‐label study of alprazolam in five bipolar‐I depressed patients, three patients remitted completely, one failed to respond, and one responded transiently, based on the Hamilton Rating Scale and Beck Depression Inventory scores. Further studies of alprazolam as an antidepressant are warranted.
A J, Rush +3 more
openaire +2 more sources
Unipolar depression/bipolar depression: Connections and controversies
International Review of Psychiatry, 2005The modern dichotomous divide between unipolar and bipolar depressive disorders derives from several monographs that appeared in the mid-twentieth century. Studies of illness course and differing symptomatic profiles in unipolar and bipolar illness support this interpretation, but more recent descriptions of 'bipolar spectrum disorders' and genetic ...
openaire +2 more sources
Unmet needs in bipolar depression
Depression and Anxiety, 2004Bipolar disorders, particularly bipolar spectrum disorders, frequently go unrecognized and undiagnosed by clinicians and thus remain untreated or inappropriately treated. Although the symptoms of bipolar I disorder are widely acknowledged and recognized among clinicians, epidemiology sampling studies over the past several years have found that bipolar ...
Mark A, Frye +2 more
openaire +2 more sources